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Ethyl alcohol (ethanol) has many molecular targets in the nervous system, its potency at these 
sites being low compared to those of sedative drugs. This has made it difficult to discover 
ethanol’s binding site(s). There are two putative binding sites at γ-aminobutyric acid (GABA) 
type A receptor subtypes for the proposed ethanol antagonist Ro 15-4513, the established 
γ2 subunit-dependent benzodiazepine site and the recently reported δ subunit-dependent Ro 
15-4513/ethanol binding site. Here, we aimed at clarifying the in vivo role of Ro 15-4513 at 
these two sites. We found that the antagonism of ethanol actions by Ro 15-4513 in wildtype 
mice was dependent on the test: an open field test showed that light sedation induced by 
1.5–1.8 g/kg ethanol was sensitive to Ro 15-4513, whereas several tests for ethanol-induced 
anxiolytic effects showed that the ethanol-induced effects were insensitive to Ro 15-4513. 
Antagonism of ethanol-induced sedation by Ro 15-4513 was unaffected in GABAA receptor 
δ subunit knockout mice. By contrast, when testing the GABAA receptor γ2 subunit F77I knock-
in mouse line (γ2I77 mice) with its strongly reduced affinity of the benzodiazepine sites for Ro 
15-4513, we found that the ethanol-induced sedation was no longer antagonized by Ro 15-4513. 
Indeed, γ2I77 mice had only a small proportion of high-affinity binding of [3H]Ro 15-4513 left as 
compared to wildtype mice, especially in the caudate–putamen and septal areas, but these 
residual sites are apparently not involved in ethanol antagonism. In conclusion, we found that 
Ro 15-4513 abolished the sedative effect of ethanol by an action on γ2 subunit-dependent 
benzodiazepine sites.
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actions in animal models (Suzdak et al., 1986, 1988; Bonetti et al., 
1988). Although Ro 15-4513’s efficacy as an alcohol antagonist was 
later not found high enough for clinical development, the mecha-
nisms of action of this compound are still of interest.
Ro 15-4513 binds to all known GABAA receptor γ2 subunit-
dependent benzodiazepine binding sites irrespective of the α or 
β variants (Luddens and Wisden, 1991; Wisden et al., 1991; Korpi 
et al., 2002). It usually acts as a partial inverse agonist at GABAA 
receptors (Bonetti et al., 1988; Hadingham et al., 1993; Korpi et al., 
2002), except for α4 and α6 subunit-containing ones in which it 
acts as an agonist (Hadingham et al., 1996; Knoflach et al., 1996; 
Wafford et al., 1996). Some reports suggested that Ro 15-4513 
inhibits ethanol-induced potentiation of GABAA receptor func-
tion in brain membrane vesicles and cultured neurons (Suzdak 
et al., 1986; Mehta and Ticku, 1988), making this simple receptor 
antagonism the possible mode of action. More recently, ethanol has 
been suggested to competitively inhibit the binding of Ro 15-4513 
to α4/6βδ subunit-containing GABAA receptors (Hanchar et al., 
2006; Wallner et al., 2006). For some neuronal classes (cerebellar 
granule cells, thalamic relay neurons, dentate granule cells), these 
receptor subtypes make up a large portion of extrasynaptic recep-
tors that are exceptionally sensitive to GABA, and which do not 
IntroductIon
Ethanol (ethyl alcohol) is a poorly discriminating pharmacological 
compound targeting various proteins in the central nervous system. 
As the dose increases, ethanol causes anxiolysis, loss of exploration, 
muscle relaxation and ataxia, sedation, and finally loss of righting 
reflex and hypnosis (Deitrich et al., 1989; Spanagel, 2009). The costs 
of alcoholism to society are immense (e.g., Olesen and Leonardi, 
2003; Nutt et al., 2010); and in Finland more alcohol-caused deaths 
occur yearly than casualties in traffic accidents (Causes of Death 
2008, 2010); in the UK, alcohol is considered the drug which does 
the most harm to society (Nutt et al., 2010). Therefore, a potent and 
efficient alcohol antagonist would be important to develop. To that 
end, reports on ethyl-8-azido-5,6-dihydro-5-methyl-6-oxo-4H-im-
idazo-1,4-benzodiazepine-3-carboxylate (Ro 15-4513), an imida-
zobenzodiazepine compound acting via the benzodiazepine sites of 
γ-aminobutyric acid type A receptors (GABAA), initially provoked 
enormous interest as this compound seemed to inhibit ethanol’s 
Abbreviations: ANOVA, analysis of variance; GABA, γ-aminobutyric acid; γ2I77 
mice, knock-in mice with GABAA receptor γ2 subunit F77I mutation; Ro 15-4513, 
ethyl-8-azido-5,6-dihydro-5-methyl-6-oxo-4H-imidazo-1,4-benzodiazepine-3-
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Genotyping was performed as described (Mihalek et al., 1999). Male 
C57BL/6J mice for open arena experiments were obtained from 
central animal facility (ZVTE) of the University Medical Center 
Mainz (n = 45, aged 2–4 months, 25–30 g).
Generation of the γ2I77 mouse line has been described (Cope 
et al., 2004). In brief, the γ2I77 mouse line was generated by mating 
male chimeras (C57BL/6J × 129ola) containing γ2I77 mutation with 
wildtype C57BL/6J females (Charles River Deutschland, Sulzfeld, 
Germany) to obtain heterozygous γ2F77/γ2I77 founder pairs as 
described (Cope et al., 2004). The γ2I77 mouse line used in our 
experiments was backcrossed at least four times with C57BL/6 mice 
(Harlan Netherlands, Horst, Netherlands). Heterozygous breed-
ing was used to obtain age-matched male and female littermate 
wildtype controls (n = 50, aged 3–4 months, 24–31 g males, 18–21 g 
females) and homozygous γ2I77 mice (n = 42, aged 3–4 months, 
26–31 g males, 18–22 g females) for open arena and elevated plus-
maze  experiments.  Homozygous  breeding  was  used  to  obtain 
additional γ2I77 mice (n = 130, aged 3–5 months, 21–30 g males, 
17–24 g females) for the elevated plus-maze tests. Genotyping 
was performed as described (Cope et al., 2004). To obtain brains 
for autoradiography six female homozygous γ2I77 mice and six 
wildtype littermates (five females, one male) from heterozygous 
breeding, aged about 2 months, were used.
The mice were maintained in same-sex groups of either 1–2 
(small plastic cages, 20 cm × 27 cm × 13 cm) or 4–8 (bigger cages, 
40 cm × 30 cm × 15 cm) with food pellets and tap water ad libitum 
at standard housing conditions (12 h light–dark cycle, lights on 
at 6:00 A.M.; temperature, 20–23°C; relative humidity, 50–60%; 
aspen chip beddings).
All animal tests were carried out in accordance to the European 
Communities Council Directive of 24 November 1986 (86/609/EEC) 
and approved by the Laboratory Animal Committee of the Southern 
Finland Provincial Government and the Landesuntersuchungsamt 
Rheinland-Pfalz, Koblenz. All efforts were made to minimize the 
number and suffering of the experimental animals.
BEHAVIorAL ASSAYS
To test for exploratory locomotor activity and ethanol-induced 
sedation, the mice were individually placed on a novel arena for 
5 min (Linden et al., 2006; Chandra et al., 2010). Total locomotor 
activity of mice were analyzed automatically by following the center 
of the animal’s surface area monitored from above using a video 
tracking system with EthoVision 3.0 software (Noldus Information 
Technology, Wageningen, Netherlands). The number of rearing 
events was recorded by the experimenter from a video monitor. 
Lighting was adjusted to obtain light level of approximately 175 lux 
in the center of the arena. The arena was cleaned after each ani-
mal with diluted sodium hypochlorite solution (active chlorine 
approximately 0.005%).
To examine anxiety-related behaviors the mice were tested in an 
elevated plus-maze as described (Linden et al., 2006). The elevated 
plus-maze was made of gray plastic and elevated 50 cm from the 
floor level. It consisted of a central platform (5 cm × 5 cm), two 
open arms (5 cm × 40 cm with a 0.2 cm margin), and two enclosed 
arms (5 cm × 40 cm × 20 cm; Lister, 1987b). The mice were placed 
individually on the central platform facing the open arm and 
desensitize. Such α4βδ and α6βδ GABAA receptors produce tonic 
inhibitory currents (Brickley et al., 2001; Chandra et al., 2006). It 
is also important to note that the α4 and α6 subunits combine 
recombinantly and in vivo with the γ2 subunit, and not just with 
the δ subunit (Wisden et al., 1991). For example in the cerebellar 
granule cells there will be α6βδ and α6βγ2 and/or α1/6βγ2 recep-
tors (Wisden et al., 1996) and in the hippocampal CA1 pyramidal 
cells there will be α4βγ2 receptors and probably in other forebrain 
cell types as well (Olsen and Sieghart, 2008).
In an alcohol- and benzodiazepine-sensitive selectively bred 
rat line (Korpi et al., 1993) and more recently in outbred Wistar 
rats (Hanchar et al., 2005) the α6 subunit gene was found to have 
a point mutation (R100Q) which increases affinity to benzodi-
azepine agonists. Whereas the experiments in Wistar rats suggested 
that some effects of alcohol are enhanced by the mutated α6Q100 
subunit-containing GABAA receptor (Hanchar et al., 2005), the 
same conclusion could not be made for the selectively bred rats, 
since increased alcohol sensitivity was not genetically segregating 
with the point mutation in the α6 subunit in the F2 generations 
of the cross between alcohol-sensitive and alcohol-insensitive rat 
lines (Sarviharju and Korpi, 1993; Botta et al., 2007).
From previous work, the mechanism of the alcohol antagonis-
tic action of Ro 15-4513 might then be either the general inverse 
agonism of GABAA receptors at the established non-α4/non-α6 
benzodiazepine sites (e.g., α1βγ2, α2βγ2, α3βγ2, and α5βγ2) and/
or the selective inhibition of ethanol binding to specific non-
benzodiazepine Ro 15-4513 binding sites of GABAA receptors 
with δ subunits. Here, we have tested these two modes of action 
with two mouse lines. Firstly, we used the GABAA receptor δ subu-
nit knockout mouse line (Mihalek et al., 1999), which should 
remove α4βδ- and α6βδ-dependent high-affinity ethanol sites 
while ethanol antagonism by Ro 15-4513 could still be mediated 
via inverse agonism of α1/2/3/5βγ2 subunit-containing receptors. 
Secondly, we used the γ2I77 knock-in mouse line (Cope et al., 
2004, 2005; Leppa et al., 2005) that carry a point mutation engi-
neered into their γ2 subunit genes at the amino acid position 77, 
replacing phenylalanine (F) with isoleucine (I) and thus globally 
altering benzodiazepine pharmacology in the brain by greatly 
decreasing the affinity to the agonist zolpidem and the inverse 
agonist DMCM (methyl-6,7-dimethoxy-4-ethyl-β-carboline-3-
carboxylate) as well as to Ro 15-4513 (Buhr et al., 1997; Wingrove 
et al., 1997; Ogris et al., 2004; Cope et al., 2005). This renders γ2I77 
animals ideal as a complimentary tool to the δ-deficient mouse 
line to test whether possible high-affinity ethanol sites depend-
ent on the δ subunit are obligatory for the ethanol antagonism 
by Ro 15-4513.
MAtErIALS And MEtHodS
AnIMALS
Generation of the δ−/− mouse line has been described (Mihalek et al., 
1999). The genetic background of the mice obtained from Gregg E. 
Homanics from the University of Pittsburgh was C57BL/6J × strain 
129Sv/SvJ. In Mainz, heterozygous mice were bred to obtain age-
matched male and female littermate wildtype controls (n = 16, aged 
3–8 months, 23–36 g males, 20–27 g females) and homozygous δ−/− 
mice (n = 18, aged 3–8 months, 24–34 g males, 20–28 g females). www.frontiersin.org  January 2011  | Volume 5  | Article 3  |  3
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GABAA receptor γ1 subunit,
5′-ATGCAAGGTTCCGTATTCCATGAGTGCTGCAAACACAAA
AATGAA-3′; GABAA receptor γ2 subunit,
5′-GTGTCTGGAATCCAGATTTTCCCCACCATATTGCTATTC
AAC-3′;
GABAA receptor γ3 subunit,
5′-AGAGGGTGCTTGAAGGCTTATTCGATCAGGAATCCATCT
TGTTGA-3′.
druGS
Ethanol (94% w/w) was diluted with saline to 10% w/v and 
injected at volumes of 10, 15, or 18 ml/kg for the doses of 1.0, 1.5, 
and 1.8 g/kg, respectively. Ro 15-4513 (Tocris) was first carefully 
dissolved in 100% Tween 80 (Sigma, St. Louis, MO, USA; final 
concentration 3%) and then brought to the final concentration 
with saline or if co-administered with ethanol with 10% ethanol. 
Thus, the final Ro 15-4513 concentration was 0.167 or 0.3 mg/ml 
in the tests with 1.8 or 1 g/kg doses of ethanol, respectively. When 
Ro 15-4513 was administered 15 min before 1.5 g/kg ethanol, the 
drug suspension in Tween 80 was brought to the final 0.3 mg/ml 
concentration with saline and injected at a volume of 10 ml/kg.
StAtIStIcAL tEStInG
All data are given as means ± SEM. Three-way analysis of variance 
(ANOVA) was used to test main drug, genotype and sex effects (SPSS 
15.0 for Windows, SPSS Inc., Chicago, IL, USA). If no significant sex 
effect was found, the data from males and females were combined for 
post hoc Newman–Keuls multiple comparison test, or for Student’s 
t-test or Mann–Whitney analyses (GraphPad Prism 5.00, San Diego, 
CA, USA). The limit for significance was p < 0.05.
rESuLtS
ro 15-4513 rEVErSEd EtHAnoL-InducEd SEdAtIon In GABAA 
rEcEPtor δ SuBunIt-dEFIcIEnt MIcE
Male and female δ−/− and littermate wildtype δ+/+ mice were 
administered first 3 mg/kg Ro15-4513, then 15 min later 1.5 g/kg 
ethanol, and 10 min later they were individually placed in an open 
arena (59 cm × 59 cm) for a 5-min test of locomotor activity.
Three-way ANOVA revealed a significant drug effect (F2,22 = 6.8, 
p < 0.01) on the percent time moving, but no sex effect or interac-
tion. Therefore, the data of males and females were pooled (drug 
effect F2,28 = 5.8, p < 0.01 in two-way ANOVA) for subsequent 
analysis (Figure 1). Ethanol appeared to slightly reduce total loco-
motor activity (i.e., it induced a sedative effect) in both wildtype 
and δ−/− mice. However, this reduction was significant (p < 0.05) 
only  in  the  knockout  mice  (Figure  1).  Importantly,  pretreat-
ment with Ro 15-4513 prevented this ethanol-induced reduction 
(Figure 1). Since no genotype effect was in locomotor activity, 
we pooled the wildtype and knockout values to analyze the effect 
of ethanol and its combination with Ro 15-4513. Ethanol alone 
significantly (p < 0.01, one-way ANOVA followed by Student’s 
t-test) reduced locomotor activity compared to vehicle treatment 
(47.7 ± 4.6 vs. 67.5 ± 4.2% time moving, n = 10–12, respectively), 
whereas ethanol + Ro 15-4513 (65.4 ± 4.1, n = 12) did not differ 
from vehicle values, but was significantly (p < 0.01) higher than 
the values for ethanol alone.
allowed free exploration of the maze for 5 min. An arm entry was 
recorded when the center of the mouse entered the arm at least 
2 cm distal from the central platform. This corresponds to the 
definition of an arm entry with all four legs on the arm. Lighting 
was adjusted to obtain light level of approximately 20 lux in the 
central platform for tests with γ2I77 mice. The maze was cleaned 
after each animal with diluted sodium hypochlorite solution or 
with water. Testing of γ2I77 mice was performed in a quiet room 
adjacent to housing rooms. In the elevated plus-maze testing of 
δ−/− mice, lighting level was higher (exact level not determined), 
the maze was cleaned with water, a radio needed to be on to stand-
ardize background noise level, and the testing room was separate 
from housing rooms.
QuAntItAtIVE LIGAnd AutorAdIoGrAPHY
Flumazenil-sensitive [3H]Ro 15-4513 binding was determined in 
various brain regions as described (Makela et al., 1997). In brief, 
horizontal sections using a Leica CM 3050 S cryostat were cut from 
six brains for both genotypes, thaw-mounted onto gelatin-coated 
object glasses (Menzel GmbH, Braunschweig, Germany) and prein-
cubated for 15 min in an ice-water bath in incubation buffer [50 mM 
Tris–HCl, 120 mM NaCl (pH 7.4)]. The final incubation took place 
with 15 nM [3H]Ro 15-4513 (Perkin-Elmer, Boston, MA, USA) in 
fresh buffer in the dark at +4°C for 60 min in plastic slide mailers. 
The required amount of the radioisotope in ethanol was evaporated 
to dryness under vacuum and taken up into a similar volume of 
dimethyl sulfoxide. Effects of 1–100 mM ethanol (Altia, Rajamäki, 
Finland) on radioligand binding were determined. Non-specific 
binding was determined with 10 μM flumazenil (Ro 15-1788; Tocris 
Biosciences, Ellisville, MO, USA). After incubation, the sections 
were washed with ice-cold incubation buffer for 2 × 60 s, dipped 
in distilled water, and dried in air flow at room temperature. The 
sections were exposed to Kodak Biomax MR film (Eastman Kodak, 
Rochester, NY, USA) for 8 weeks with [3H]microscale standards (GE 
Healthcare, Little Chalfont, Buckinghamshire, UK). For quantifi-
cation of binding densities, the films were first scanned with the 
standards and then relevant brain regions analyzed with MCID M5 
image analysis devices and programs (Imaging Research Inc., St. 
Catharines, ON, Canada). Binding densities were converted to nCi/
mg radioactivity values on the basis of the simultaneously exposed 
standards. Non-specific binding in the presence of flumazenil was 
at the background level in sections of both mouse lines, except 
for some faint binding left in the cerebellar granule cell layer of 
wildtype sections (Figure 8). This component was not subtracted 
from the total binding. Representative images were obtained by 
scanning the films using an Epson expression 1680 Pro scanner.
IN SITU HYBrIdIZAtIon
In situ hybridization with 35S-labeled oligonucleotide probes was 
as described (Wisden et al., 1992; Wisden and Morris, 2002). Brain 
cryostat sections from adult γ2I77 mice were used. Images were 
generated from 4 to 12 week exposures to Kodak Biomax MR X-ray 
films. To assess non-specific labeling of the sections, each labeled 
oligonucleotide was hybridized to brain sections with a 100-fold 
excess of unlabeled oligonucleotide. Oligonucleotide sequences 
were as follows:Frontiers in Neuroscience  |  Neuropharmacology    January 2011  | Volume 5  | Article 3  |  4
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both wildtype and γ2I77 mice (Figure 3A), and that this reduction 
was completely prevented in the wildtype mice by co-administra-
tion with Ro 15-4513. In γ2I77 mice, Ro 15-4513 failed to prevent 
this effect of ethanol. Ro 15-4513 alone did not affect locomotion 
in either wildtype or γ2I77 mice (Figure 3A).
Ethanol treatment reduced the number of rearings in both geno-
types but this reduction was not prevented by Ro 15-4513 in either 
genotype (Figure 3B). Consistently, two-way ANOVA displayed 
drug (F3,84 = 40.6, p < 0.001) and genotype (F1,84 = 6.4, p < 0.05) 
effects without an interaction. The slightly lower number of rearing 
events in all treatment groups of γ2I77 mice compared to the cor-
responding wildtype values likely explains the significant genotype 
effect in two-way ANOVA.
ELEVAtEd PLuS-MAZE BEHAVIor AFtEr AdMInIStrAtIon oF EtHAnoL 
And ro 15-4513 In tHE WILdtYPE And γ2I77 MIcE
Ethanol (1 g/kg, i.p.) and Ro 15-4513 (3 mg/kg) were co-admin-
istered to male and female γ2I77 and wildtype littermate γ2F77 
mice 10 min before the elevated plus-maze test. Three-way ANOVA 
revealed no sex effects in the behaviors, and, therefore, the male 
and female data were combined (Figure 4). The percent time spent 
on the open arms was significantly affected by drug treatment 
(F3,106 = 3.9, p < 0.05, two-way ANOVA), but not by genotype, and 
no genotype × drug interaction emerged. The only groups that were 
significantly different from the vehicle-treated mice in the post hoc 
comparisons were the ethanol-treated and Ro 15-4513 + ethanol-
treated γ2I77 mouse groups. They spent more time on the open 
arms compared to vehicle-treated γ2I77 mice (Figure 4A). The 
number of open-arm entries was also significantly affected by drug 
treatment (F3,106 = 3.6, p < 0.05, two-way ANOVA). However, differ-
ences between the treatment groups were not significant in post hoc 
comparisons in either genotype (Figure 4B).
AntAGonISM oF 1.8 G/kG EtHAnoL-InducEd SEdAtIon BY ro 15-4513 
In c57BL/6J MIcE
Next, we tested whether Ro 15-4513 could inhibit sedation induced 
by a slightly higher dose (1.8 g/kg) of ethanol because the reduc-
tion in locomotor activity by the 1.5-g/kg dose barely reached sta-
tistical significance in the test described above. In C57BL/6J male 
mice, 1.8 g/kg ethanol significantly reduced locomotor activity in 
an open arena (59 cm × 59 cm) as verified in post hoc tests fol-
lowed by one-way ANOVA (drug effects F3,41 > 16.5, p < 0.0001; 
Figures 2A,B). Importantly, Ro 15-4513 (3 mg/kg), co-adminis-
tered at the same time as ethanol, completely inhibited the etha-
nol-induced reduction in total locomotor activity and partly the 
reduction in rearing (Figures 2A,B). Ro 15-4513 alone had no effect 
on locomotor activity.
ro 15-4513 FAILEd to rEVErSE EtHAnoL-InducEd SEdAtIon In  
γ2I77 MIcE
Ethanol (1.8 g/kg) was administered to male and female γ2I77 and 
littermate wildtype γ2F77 mice with or without 3 mg/kg Ro15-4513 
and the mice were tested on an open arena (50 cm × 50 cm) 10 min 
later. Three-way ANOVA revealed no sex effect or interaction and 
therefore the data of males and females could be pooled without 
reservations for subsequent analysis. Two-way ANOVA showed that 
locomotor activity was significantly affected by drug treatments 
(F3,84 = 17.2, p < 0.001) and genotype (F1,84 = 12.3, p < 0.01) and 
that genotype × drug interaction (F3,84 = 5.6, p < 0.01) emerged. 
Post hoc comparisons verified that ethanol reduced locomotion in 
FIGURE 1 | Ethanol-induced reduction in total locomotor activity was 
reversed by pretreatment with Ro 15-4513 in δ−/− mice. Male and female 
δ−/− and littermate wildtype δ+/+ mice were pretreated with 3 mg/kg Ro 
15-4513 (i.p.) or vehicle (Veh) 15 min before administration of 1.5 g/kg ethanol 
(EtOH; i.p.) and tested 10 min later on a novel arena for 5 min for total 
locomotor activity analyzed as percent time moving of the total testing time. 
#p < 0.05 compared to vehicle controls within the same genotype (one-way 
ANOVA followed by Student’s t-test). The data of males and females were 
pooled. n = 5–7 .
FIGURE 2 | Reversal of ethanol-induced reduction in total locomotor 
activity by Ro 15-4513 in wildtype mice. Male C57BL/6J mice were 
co-administered with 1.8 g/kg ethanol (EtOH) and 3 mg/kg Ro15-4513 (or 
vehicle, Veh) 10 min before being tested on a novel arena for 5 min. (A) 
Co-treatment with Ro 15-4513 reversed ethanol-induced reduction in total 
locomotor activity. (B) Co-treatment with Ro 15-4513 attenuated ethanol-
induced reduction in rearing. ##p < 0.01, ###p < 0.001 compared to vehicle 
treatment; p < 0.001 compared to ethanol treatment (one-way ANOVA 
followed by Newman–Keuls test). n = 9–17 .www.frontiersin.org  January 2011  | Volume 5  | Article 3  |  5
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FIGURE 3 | Ro 15-4513 reversed ethanol-induced reduction in total 
locomotor activity in wildtype γ2F77 mice, but not in γ2I77 knock-in 
mice. Male and female γ2I77 and littermate wildtype γ2F77 mice were 
co-administered with 1.8 g/kg ethanol and 3 mg/kg Ro15-4513 (or vehicle, Veh) 
10 min before being tested on a novel arena for 5 min. (A) Ro 15-4513 
reversed ethanol-induced reduction in total locomotor activity in the γ2F77 , 
but not in γ2I77 mice. (B) Ro 15-4513 failed to reverse ethanol-induced 
reduction in rearing both in the γ2F77 and γ2I77 mice. Because three-way 
ANOVA revealed no sex effect or interaction the data of males and females 
were pooled. ***p < 0.001 compared to similarly treated γ2F77 mice; 
###p < 0.001 compared to vehicle controls within the same genotype; 
p < 0.001 compared to ethanol treatment within the same genotype 
(one-way ANOVA followed by Newman–Keuls multiple comparison test). 
n = 10–14.
The percent time spent on the closed arms was not significantly 
affected by drug treatment or genotype (Figure 4C). However, 
the number of closed-arm entries was affected by drug treatment 
(F3,106 = 2.8, p < 0.05, two-way ANOVA) without genotype effect 
or genotype × drug interaction. Post hoc comparisons showed 
that the ethanol-treated and Ro 15-4513 + ethanol-treated γ2I77 
mice visited significantly less frequently the closed arms than 
the vehicle-treated γ2I77 mice (Figure 4D). The dose of 1 g/kg 
ethanol or its combination with Ro 15-4513 (3 mg/kg) did not 
cause sedation as the amount of total movements was not sig-
nificantly affected by drug treatment (p > 0.05, two-way ANOVA; 
Figure 4E).
It should be noted that we excluded from the results 5 (2 males 
and 3 females) out of 20 (25%) Ro 15-4513 + ethanol-treated γ2I77 
mice; 1 (male) out of 14 (7.1%) Ro 15-4513 + ethanol-treated 
wildtype mice; and 1 (male) out of 13 (7.7%) ethanol-treated 
wildtype mice because they fell down from the maze during the test. 
Thus, the mean values of especially Ro 15-4513 + ethanol-treated 
γ2I77 mice may be biased by the inability of the most sensitive 
animals to perform the test.
In  order  to  analyze  the  effects  of  ethanol  on  open-arm 
behaviors and the actions of Ro 15-4513 on them we pooled 
the data of γ2I77 and wildtype γ2F77 mice, since no genotype 
effect emerged in two-way ANOVA. Ethanol treatment increased 
significantly (p < 0.01, one-way ANOVA followed by Student’s 
t-test) the percent time spent in the open arms compared to 
vehicle treatment (20.7 ± 2.7 vs. 12.5 ± 2.0, n = 31, respectively). 
The open-arm time was also significantly (p < 0.01) longer in Ro 
15-4513 + ethanol-treated mice (23.8 ± 3.5, n = 28). Similarly, 
ethanol treatment increased significantly (p < 0.05) the number 
of open-arm visits compared to vehicle treatment (10.7 ± 1.1 
vs. 7.7 ± 0.7, n = 31, respectively), and they were also signifi-
cantly increased (p < 0.05) in Ro 15-4513 + ethanol-treated mice 
(11.2 ± 1.2, n = 28).
In another elevated plus-maze experiment, the effect of co-
administering Ro 15-4513 (3 mg/kg) and ethanol (1 g/kg) were 
tested in γ2I77 mice obtained from homozygous breeding. In this 
test the maze was cleaned with water, not with diluted sodium 
hypochlorite solution. We excluded 2 (females) out of 27 (7.4%) 
ethanol-treated mice because they fell down from the maze dur-
ing the test. Two-way ANOVA revealed no sex effects. The Ro 
15-4513 + ethanol-treated γ2I77 mice spent significantly more 
time on the open arms compared to the vehicle-treated mice 
(F3,92 = 2.8, p < 0.05, two-way ANOVA; Figure 5A). The number 
of open-arm entries was also significantly affected by drug treat-
ment (F3,92 = 3.2, p < 0.05). However, differences between the treat-
ment groups did not reach significance in post hoc comparisons 
(Figure 5B). Although, the drug treatments did not alter the time 
spent on the closed arms, the number of closed-arm entries was 
significantly affected by drug treatment (F3,92 = 4.6, p < 0.01), and 
the Ro 15-4513 + ethanol-treated γ2I77 mice visited significantly 
less  frequently  the  closed  arms  than  the  vehicle-treated  mice 
(Figure 5D). Total movements were not significantly affected by 
drug treatments (Figure 5E).
ELEVAtEd PLuS-MAZE BEHAVIor AFtEr EtHAnoL And ro 15-4513 
AdMInIStrAtIon In tHE δ SuBunIt-dEFIcIEnt MIcE
Interactions of ethanol and Ro 15-4513 on elevated plus-maze 
behaviors were also analyzed in δ−/− and littermate δ+/+ mice 
(Figure 6). However, testing conditions differed considerably 
from those of γ2I77 mice (Figures 4 and 5) as explained in the 
Methods. Changes in experimental conditions probably explain 
the baseline differences in vehicle-treated wildtype mice in these 
tests performed in different laboratories. Ethanol (1 g/kg, i.p.) 
and Ro 15-4513 (3 mg/kg) were co-administered to male and 
female mice 10 min before the test. Three-way ANOVA revealed 
no sex effects in the behaviors, and, therefore, the male and female 
data were combined (Figure 6). The percent time spent on the Frontiers in Neuroscience  |  Neuropharmacology    January 2011  | Volume 5  | Article 3  |  6
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in both genotypes (Figure 6C). No sedation was observed as the 
amount of total movements was not significantly affected by drug 
treatments (Figure 6E).
In order to analyze drug effects on open-arm behaviors we 
pooled the data of wildtype and knockout mice because no geno-
type effect emerged in two-way ANOVA. Open-arm time was not 
significantly affected. However, ethanol treatment increased signifi-
cantly (p < 0.01, one-way ANOVA followed by Student’s t-test) the 
number of visits to the open arms compared to vehicle treatment 
open arms was not significantly affected by drug treatment or 
genotype, and no genotype × drug interaction emerged (two-way 
ANOVA; Figure 6A). However, the number of open-arm entries 
was significantly affected by drug treatment (F2,31 = 5.8, p < 0.01, 
two-way ANOVA). Differences between the treatment groups 
reached significance in post hoc comparisons in the wildtype 
mice only (Figure 6B). The percent time spent on the closed 
arms was significantly affected by drug treatment (F2,31 = 10.1, 
p < 0.01, two-way ANOVA), and the effect of ethanol was seen 
FIGURE 4 | Effects of ethanol and its combination with Ro 15-4513 on 
elevated plus-maze behavior in wildtype γ2F77 and γ2I77 knock-in mice. 
Male and female γ2I77 and littermate wildtype γ2F77 mice were co-
administered with 1 g/kg ethanol (EtOH) and 3 mg/kg Ro15-4513 (or vehicle, 
Veh) 10 min before being tested for anxiolytic-like behavior on an elevated 
plus-maze for 5 min. (A) The percent time spent in the open arms of the total 
testing time. (B) The number of open-arm entries. (C) The percent time spent in 
the closed arms of the total testing time. (D) The number of closed-arm entries. 
(E) Total movements. Because three-way ANOVA revealed no sex effect or 
interaction the data of males and females were pooled. #p < 0.05, ##p < 0.01 
compared to vehicle-treated mice within the same genotype (one-way ANOVA 
followed by Student’s t-test). n = 10–19.www.frontiersin.org  January 2011  | Volume 5  | Article 3  |  7
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15 nM, which is more than twofold the Kd for native wildtype GABAA 
receptors (Uusi-Oukari and Korpi, 1990), the results should be indica-
tive of the number of binding sites. Interestingly, clear residual binding 
was detectable in the septal nuclei and caudate–putamen (Figure 7A; 
Table 1), amounting to approximately 13% of the wildtype levels.
 Ethanol, at concentrations ranging from 1 to 100 mM only 
marginally, if at all, affected [3H]Ro 15-4513 binding (Figure 8) 
in wildtype and γ2I77 brain sections. The binding levels in the 
six brain regions analyzed (the same as in Table 1), were between 
96–109% and 80–108% of the basal binding in the γ2F77 and γ2I77 
brains, respectively (data not shown), thus contrasting with the 
proposed competitive inhibition of [3H]Ro 15-4513 binding by 
low millimolar concentrations of ethanol in native bovine GABAA 
receptors (Hanchar et al., 2006).
 Figure 7B shows the expression patterns for the GABAA receptor 
γ1, γ2, and γ3 subunit genes in adult γ2I77 brain sections. Whereas 
the γ2 mRNA gene expression is the most widespread, the γ1 and γ3 
genes do have discrete expressions in, for example, septal nuclei and 
(9.8 ± 1.5 vs. 3.7 ± 0.6, n = 10–12, respectively). The open-arm visits 
were also significantly (p < 0.01) increased in Ro 15-4513 + ethanol-
treated mice (9.1 ± 1.7, n = 10).
BIndInG oF [3H]ro 15-4513 to BrAIn SEctIonS FroM WILdtYPE And 
γ2I77 MIcE: EFFEctS oF EtHAnoL
Horizontal brain sections from adult wildtype littermate γ2F77 ani-
mals showed a wide, but regionally varying distribution of [3H]Ro 
15-4513 binding to flumazenil-sensitive benzodiazepine binding sites, 
in agreement with previous studies (Sieghart et al., 1987; Uusi-Oukari 
and Korpi, 1990; Turner et al., 1991; Figure 7A). The cerebral cor-
tex and hippocampus had more than twofold more binding than 
the caudate–putamen, septal nuclei, and cerebellar granule cell layer 
(Table 1). In γ2I77 mouse brain sections, the binding was massively 
reduced throughout the brain, indicating a decreased affinity of [3H]
Ro 15-4513 to point-mutated receptors (see Ogris et al., 2004 for phar-
macological comparisons of wildtype and γ2I77 mutant brain mem-
branes). Since we used [3H]Ro 15-4513 at the ligand concentration of 
FIGURE 5 | Effects of ethanol and its combination with Ro 15-4513 on 
elevated plus-maze behavior in γ2I77 knock-in mice. Male and female γ2I77 
mice were co-administered with 1 g/kg ethanol (EtOH) and 3 mg/kg Ro 15-4513 
(or vehicle, Veh) 10 min before being tested on the elevated plus-maze for 5 min. 
(A) The percent time spent in the open arms of the total testing time. (B) The 
number of open-arm entries. (C) The percent time spent in the closed arms of 
the total testing time. (D) The number of closed-arm entries. (E) Total 
movements. Because two-way ANOVA revealed no sex effect or interaction the 
data of males and females were pooled. #p < 0.05, ##p < 0.01 compared to 
vehicle-treated mice (one-way ANOVA followed by Student’s t-test). n = 24–26.Frontiers in Neuroscience  |  Neuropharmacology    January 2011  | Volume 5  | Article 3  |  8
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dIScuSSIon
Our main finding here was that Ro 15-4513 could reverse the 
sedative effect (i.e., the reduction of horizontal locomotor activ-
ity) produced by relatively low doses of ethanol (1.5–1.8 g/kg) in 
δ−/− knockout mice, but not in γ2I77 mice. Thus, the ability of 
Ro 15-4513 to antagonize this particular sedative effect of ethanol 
the rostral caudate–putamen (γ3; Ymer et al., 1990; Herb et al., 1992; 
Wisden et al., 1992). Therefore, since the benzodiazepine receptor 
forms at the interface of the α and γ subunits (Sigel and Buhr, 
1997), the residual flumazenil-sensitive [3H]Ro 15-4513 binding 
in γ2I77 mice probably originates from αβγ1 and/or αβγ3 subunit-
containing GABAA receptors.
FIGURE 6 | Effects of ethanol and its combination with Ro 15-4513 on 
elevated plus-maze behavior in δ+/+ and δ−/− mice. Male and female 
δ−/− and littermate wildtype δ+/+ mice were co-administered (i.p.) with 1 g/kg 
ethanol (EtOH) and 3 mg/kg Ro15-4513 (or vehicle, Veh) 10 min before being 
tested for anxiolytic-like behavior on an elevated plus-maze for 5 min. (A) The 
percent time spent in the open arms of the total testing time. (B) The number of 
open-arm entries. (C) The percent time spent in the closed arms of the total 
testing time. (D) The number of closed-arm entries. (E) Total movements. 
Because three-way ANOVA revealed no sex effect or interaction the data of 
males and females were pooled. #p < 0.05, ##p < 0.01 compared to vehicle-
treated mice within the same genotype (one-way ANOVA followed by Student’s 
t-test). n = 4–7 .www.frontiersin.org  January 2011  | Volume 5  | Article 3  |  9
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concentrations at 5- and 15-min time points, respectively (Pastino 
et al., 1996), while 1 g/kg (i.p.) ethanol produces approximately 
20 mM at the 20-min time point (Lallemand and de Witte, 2005). It 
could be argued that Ro 15-4513 only antagonizes very low ethanol 
concentrations, but it is difficult to test its efficacy in any behaving 
mouse model due to inconsistent behavioral effects of low ethanol 
doses. However, drugs that antagonize low alcohol doses are not 
needed in the clinic. In contrast, an efficient antagonist for alcohol 
poisoning (ethanol levels at or over 60–80 mM) is urgently needed, 
but this is an effect that Ro 15-4513 lacks (Nutt et al., 1988).
Our results with δ−/− mice indicate that δ subunit-containing 
GABAA receptors are dispensable for Ro 15-4513 to antagonize 
the light sedation produced by a 1.5-g/kg dose of ethanol. This is 
consistent with Ro 15-4513 shortening ethanol (3.5 g/kg)-induced 
loss of righting reflex in δ−/− mice similarly as for wildtype mice 
(Mihalek et al., 2001). Anxiolytic and hypnotic effects of etha-
nol were unaltered in δ−/− mice, whereas ethanol consumption, 
withdrawal responses, and anticonvulsant effects were affected 
(Mihalek et al., 2001).
We analyzed the effect of Ro 15-4513 on behaviors induced by 
a low dose of ethanol, and tested its effects on ethanol-induced 
anxiolytic-like behavior in the elevated plus-maze test. Ethanol 
must depend on the intact benzodiazepine site formed by the γ2 
subunit in αβγ2 receptors and only marginally or not at all on δ 
subunit-containing GABAA receptors.
The sedative ethanol doses we used produce moderate blood 
ethanol concentrations. For example, an ethanol dose of 1.6 g/kg 
(i.p.) in mice, produces approximately 40 and 35 mM blood ethanol 
FIGURE 7 | Residual benzodiazepine site binding of [3H]Ro 15-4513 to 
brain sections of γ2I77 knock-in mice as compared to the total binding in 
wildtype γ2F77 mice. (A) Total [3H]Ro 15-4513 binding to horizontal sections 
from adult wildtype γ2F77 and γ2I77 mice, showing on the left an optimized 
image for the γ2F77 section, on the right an optimized image for the residual 
binding to mutant mouse section, and in the middle the same γ2F77 image 
using the settings optimized for the mutant. The mean percentage values of 
the residual binding are given for those areas that show significant binding. 
(B) In situ hybridization signals for specific oligonucleotide probes for mRNAs 
of the three γ subunit genes in sections from adult γ2I77 mice.
Table 1 | Quantitative autoradiography of [3H]Ro 15-4513 binding to 
various brain regions from naïve γ2I77 and wildtype (WT) littermate 
γ2F77 mice.
Brain region  Binding density (nCi/mg)
  WT mice  γ2I77 mice (% of WT)
Cerebral cortex  68.8 ± 2.0  1.4 ± 0.1 (2.0)
Hippocampus – CA1 region  69.0 ± 1.4  1.8 ± 0.1 (2.6)
Caudate–putamen  19.8 ± 0.4  2.6 ± 0.2 (13.1)
Septal nuclei  23.7 ± 0.8  3.2 ± 0.3 (13.5)
Thalamus  28.1 ± 0.9  0.9 ± 0.1 (3.2)
Cerebellar granule cell layer  32.9 ± 1.1  0.6 ± 0.1 (1.8)
Values are means ± SEM for six mice per group. Estimations of non-specific 
binding have not been subtracted (cf. Figure 8).Frontiers in Neuroscience  |  Neuropharmacology    January 2011  | Volume 5  | Article 3  |  10
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FIGURE 8 | Effects of ethanol (1–100 mM) on [3H]Ro 15-4513 binding to 
horizontal sections from wildtype γ2F77 and γ2I77 knock-in mice. 
Representative images for both mouse lines have been prepared using identical 
imaging settings for contrast and brightness. No consistent inhibition of the 
binding by ethanol was observed. Non-specific binding in the presence of 10 μM 
flumazenil was negligible at the background level, except for the cerebellar 
granule cell layer of wildtype brains. In that area, it amounted to about 3% of 
total binding.
alone at a dose of 1 g/kg produced a modest anxiolytic-like effect, 
i.e., open-arm activities of wildtype, γ2I77 as well as δ−/− mice 
in the elevated plus-maze test were slightly increased independ-
ently of the genotype. This anxiolytic effect was not antagonized 
by co-treatment with Ro 15-4513 in any of our experiments. In 
contrast to our results, there are reports demonstrating that Ro 
15-4513 reverses anxiolytic effects of ethanol in several differ-
ent anxiety tests including the elevated plus-maze test (Suzdak 
et al., 1986; Belzung et al., 1988; Misslin et al., 1988; Becker 
and Hale, 1991; Prunell et al., 1994). The lack of antagonism 
of ethanol’s anxiolytic-like action by Ro 15-4513 we observed 
may be related to the dosing regimen employed. Because we 
injected the drugs 10 min prior to testing, we may have analyzed 
the mice at a time point at which combining Ro 15-4513 and 
ethanol leads to some excitation. Indeed, Becker and Hale (1989) 
administered the drugs 5–6 min before testing and found that 
co-administration of ethanol and Ro 15-4513 increased locomo-
tion although neither drug alone had any effect, and Weizman 
et al. (2001) have shown that Ro 15-4513 enhances the effects 
of low ethanol doses. Moreover, at the low doses of ethanol that 
elicit excitation, Ro 15-4513 has been shown to either potentiate 
(Becker and Hale, 1989; June and Lewis, 1989) or reverse (Lister, 
1987a; Belzung et al., 1988; Misslin et al., 1988; June and Lewis, 
1994) the effect depending on the experimental animals, condi-
tions, and parameters measured.
We found inconsistent effects of Ro 15-4513 on rearing activity 
impaired by 1.8 g/kg dose of ethanol in different wildtype mice. 
Co-treatment with Ro 15-4513 partially reversed the reduction in 
rearing elicited by ethanol in C57BL/6J mice but not in the γ2F77 
mice. The lack of effect in the latter mice may have been due to 
slightly stronger sedation in that particular experiment as indi-
cated by more robust reduction in locomotor activity in γ2F77 
mice (reduction of time moving on the average from 77 to 43%) 
compared to that in C57BL/6J mice (from 82 to 56%) after ethanol 
administration.
Finally, we showed that high-affinity binding of [3H]Ro 15-4513 
requires the γ2 subunit as this binding was completely abolished in 
most forebrain regions (this study) and in the cerebellum (Korpi et al., 
2007) of γ2I77 mice. Importantly, the residual binding detected in the 
γ2I77 brain sections was not localized in regions with high δ subunit 
expression levels such as the thalamus, dentate gyrus, or cerebellar 
granule cell layer (Wisden et al., 1992). Instead, the highest propor-
tion of residual binding (approximately 13% of wildtype levels) was 
in the rostral caudate–putamen and septal nuclei suggesting that [3H]
Ro 15-4513 binds to γ3 and/or γ1 subunit-containing receptors. It has 
to be noted that, while γ3 subunit-containing receptors bind [3H]
Ro 15-4513 with high to moderate affinity (Hadingham et al., 1995; 
Lüddens and Korpi, 1995), γ1 subunit-containing receptors may not 
bind this ligand with high affinity at all (Benke et al., 1996) or have low 
efficacy (Wafford et al., 1993). The residual [3H]Ro 15-4513 binding 
was not displaced by ethanol ranging from 1 to 100 mM concen-
trations, which is in line with our earlier observations that [3H]Ro 
15-4513 binding in the wildtype C57BL/6J mouse brain was unaf-
fected by 1–100 mM ethanol (Korpi et al., 2007). Thus, we were unable 
to find evidence of γ2 subunit-independent, δ subunit-dependent Ro 
15-4513/ethanol binding sites in the γ2I77 mouse brain, consistent 
with the lack of effect of ethanol on [3H]Ro 15-4513 binding to rat 
brain homogenates (Mehta et al., 2007). In addition, the δ and β3 
subunit expression patterns are often mutually exclusive in areas such 
as many thalamic nuclei: instead the most frequent thalamic GABAA 
receptor is likely to be α4β2δ and/or α1α4β2γ2 (Wisden et al., 1991, 
1992; Belelli et al., 2005). As the β3 subunit is claimed to be indispen-
sable for the action of low concentrations of ethanol (Wallner et al., 
2003), an in vivo effect at this site (via e.g., α4β3δ) seems unlikely.www.frontiersin.org  January 2011  | Volume 5  | Article 3  |  11
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